Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin and Etoposide in Resistant AML
NCT02773732Phase 2Terminated
- Sponsor
- University of Florida
- Start
- Dec 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciprofloxacin in acute myeloid leukemia (AML), sponsored by University of Florida. Started Dec 2016; status: terminated.
02
Drugs
ciprofloxacin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02773732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773732.